• DOI:10.1038/nbt1010-996c
• Corpus ID: 35731021

Monsanto relaxes restrictions on sharing seeds for research

@article{Waltz2010MonsantoRR,
  title={Monsanto relaxes restrictions on sharing seeds for research},
  author={Emily Waltz},
  journal={Nature Biotechnology},
  year={2010},
  volume={28},
  pages={996-996}
}

• E. Waltz
• Published 13 October 2010
• Biology
• Nature Biotechnology

volume 28 number 10 oCTober 2010 nature biotechnology manufactured in the US by Novartis of Basel under license from Intercell of Vienna. Ken Eckels, who leads the research team at the Walter Reed pilot facility, has no doubt that biomanufacturing units springing up in publicly funded organizations provide a valuable service. The key, he says, is keeping up with regulatory protocols such as current good manufacturing practice and ensuring that the appropriate quality control and quality assurance checks are in place. nidhi Subbaraman Boston ments at the institute.” What’s more, the small manufacturing plant has produced the clinical grade material needed to move projects from preclinical research into phase 1/2 clinical trials, she adds. Another pilot bioproduction facility success is the Japanese encephalitis virus (JEV) purifiedinactivated vaccine, manufactured and distributed as Ixiaro (inactivated JEV strain SA14-14-2 with aluminum hydroxide adjuvant). Ixiaro received US Food and Drug Administration approval last year, and is now distributed and